Adaptive Biotechnologies unveiled a new type of test Wednesday for Lyme disease that may be most useful at detecting disease during the early stages of infection. Conventional tests for the… Read More
— Lance Baldo stepped down as chief medical officer of Adaptive Biotechnologies. Baldo is “moving on to pursue another professional opportunity in the early cancer screening market close to home,”… Read More